Tumor Protection by IL-7 Secreting Whole Cell Vaccine is Merely Mediated by NK1.1-positive CellsSCHROTEN, Caroline; SCHEFFER, Reinilde; BOON, Louis et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 2, pp 125-130, issn 1524-9557, 6 p.Article

Androgen receptor modifications in prostate cancer cells upon long-term androgen ablation and antiandrogen treatmentMARQUES, Rute B; ERKENS-SCHULZE, Sigrun; DE RIDDER, Corrina M et al.International journal of cancer. 2005, Vol 117, Num 2, pp 221-229, issn 0020-7136, 9 p.Article

The human PC346 xenograft and cell line panel : A model system for prostate cancer progressionMARQUES, Rute B; VAN WEERDEN, Wytske M; ERKENS-SCHULZE, Sigrun et al.European urology. 2006, Vol 49, Num 2, pp 245-257, issn 0302-2838, 13 p.Article

A prostate cancer vaccine comprising whole cells secreting IL-7, effective against subcutaneous challenge, requires local GM-CSF for intra-prostatic efficacySCHROTEN-LOEF, Caroline; DE RIDDER, Corrina M. A; RENEMAN, Suzanne et al.Cancer immunology and immunotherapy. 2009, Vol 58, Num 3, pp 373-381, issn 0340-7004, 9 p.Article

A small chimeric promoter for high prostate-specific transgene expression from adenoviral vectorsKRAAIJ, Robert; VAN DER WEEL, Laura; DE RIDDER, Corrina M. A et al.The Prostate. 2007, Vol 67, Num 8, pp 829-839, issn 0270-4137, 11 p.Article